Syphilis Immunoassay Diagnostics Market Growth Trends and Outlook Through 2030
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Estimated Market Size Of The Syphilis Immunoassay Diagnostics Market In 2026, And How Will Its Value Evolve By 2030?
The syphilis immunoassay diagnostics market size has experienced significant expansion in recent years. It is projected to grow from $33.5 billion in 2025 to $36.05 billion in 2026, showing a compound annual growth rate (CAGR) of 7.6%. This historical growth can be linked to the increasing occurrence of sexually transmitted infections, the broadening of routine screening programs, advancements in laboratory infrastructure, the availability of ELISA and CLIA technologies, and a heightened understanding of early syphilis diagnosis.
The syphilis immunoassay diagnostics market is projected to experience robust expansion over the coming years. This market is anticipated to reach $46.91 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.8%. This projected growth can be attributed to several factors including the rising adoption of rapid diagnostic tests, a heightened emphasis on decentralized testing models, the broadening of screening initiatives in developing areas, increasing investments in laboratory automation, and a growing demand for high-throughput diagnostic platforms. Key trends during this forecast period encompass the increasing integration of automated immunoassay analyzers, a surge in demand for high-sensitivity diagnostic kits, the expansion of point-of-care syphilis testing options, the growing incorporation of digital laboratory workflows, and a reinforced commitment to early and precise disease detection.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16806&type=smp
Which Drivers Are Supporting The Syphilis Immunoassay Diagnostics Market Growth?
The increasing prevalence of sexually transmitted diseases is anticipated to drive the expansion of the syphilis immunoassay diagnostics market moving forward. Sexually transmitted infections (STIs), also referred to as STDs, are infections predominantly transmitted through sexual contact, including vaginal, anal, and oral sex. This rise in sexually transmitted diseases is linked to factors such as declining condom use, antibiotic resistance, insufficient sexual education, evolving social and behavioral trends, associated stigma, reduced financial support for STD programs, and increased travel. Syphilis immunoassay diagnostics aid in the detection and management of sexually transmitted diseases by offering accurate and timely identification of syphilis infections, which enables appropriate treatment and prevention measures. For example, in June 2024, a report by the Terrence Higgins Trust, a UK-based organization, referencing the UK Health Security Agency (UKHSA), indicated that 401,800 sexually transmitted infections (STIs) were reported in England in 2023, marking a 5% rise from the preceding year. Thus, the growing number of sexually transmitted diseases is stimulating the syphilis immunoassay diagnostics market.
How Is Segmentation Applied In The Syphilis Immunoassay Diagnostics Market Segment Analysis?
The syphilis immunoassay diagnostics market covered in this report is segmented –
1) By Product: Analyzers, Reagents, Kits, Other Products
2) By Technology: Chemiluminescence Immunoassay (CLIA), Enzyme-Linked Immunosorbent Assay (ELISA), Other Technologies
3) By Application: Men, Women
4) By End-User: Hospitals, Blood Banks, Diagnostics Labs, Other End-Users
Subsegments:
1) By Analyzers: Automated Analyzers, Semi-Automated Analyzers, Manual Analyzers
2) By Reagents: Enzyme-Linked Immunosorbent Assay Reagents, Chemiluminescent Immunoassay Reagents, Rapid Plasma Reagin Reagents, Treponemal And Non-Treponemal Reagents
3) By Kits: ELISA Kits, Rapid Diagnostic Test Kits, CLIA Kits, Point-Of-Care Test Kits
4) By Other Products: Control And Calibration Materials, Sample Collection Devices, Ancillary Testing Accessories
Which Trends Are Expected To Impact The Syphilis Immunoassay Diagnostics Market?
Leading companies in the syphilis immunoassay diagnostics market are prioritizing the development of innovative solutions, such as rapid syphilis tests, to improve the effectiveness and precision of syphilis detection. These rapid syphilis tests are straightforward, point-of-care instruments that identify syphilis antibodies in blood or other bodily fluids within minutes, facilitating quick diagnosis and prompt treatment. For instance, in February 2023, Chembio Diagnostics Inc., a US-based point-of-care diagnostics firm specializing in infectious diseases, obtained a CLIA waiver from the FDA for its DPP HIV-Syphilis System. The DPP HIV-Syphilis System is a dual rapid test designed for the concurrent detection of antibodies to HIV 1/2 and Treponema pallidum, the bacterium that causes syphilis. This quick, 15-minute test seeks to enhance diagnosis and treatment, particularly in preventing the mother-to-child transmission of syphilis and mitigating the risk of HIV acquisition among individuals with syphilis.
Who Are The Companies Participating In The Syphilis Immunoassay Diagnostics Market Environment?
Major companies operating in the syphilis immunoassay diagnostics market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc, Abbott Laboratories, Siemens Healthineers, Becton Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories Inc, Meril Life Sciences Pvt Ltd, Randox Laboratories Ltd, SEKISUI Diagnostics, Trinity Biotech, Fujirebio, CTK Biotech Inc, bioLytical Laboratories Inc, ACON Laboratories Inc, InTec PRODUCTS INC, Quidel Corporation, Alere Inc, Ortho Clinical Diagnostics, DiaSorin Inc, Sekisui Medical, Beckman Coulter
Get The Full Syphilis Immunoassay Diagnostics Market Report:
Which Region Is The Largest In The Syphilis Immunoassay Diagnostics Market?
North America was the largest region in the syphilis immunoassay diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the syphilis immunoassay diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Syphilis Immunoassay Diagnostics Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Syphilis Immunoassay Diagnostics Market 2026, By The Business Research Company
Immunodiagnostics Market Report 2026
https://www.thebusinessresearchcompany.com/report/immunodiagnostics-global-market-report
Infectious Disease Diagnostics Testing Market Report
Diagnostic Specialty Antibodies Market Report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
